Literature DB >> 15672546

Cation transport specificity at the blood-brain barrier.

Paul R Lockman1, James H McAfee, Werner J Geldenhuys, David D Allen.   

Abstract

UNLABELLED: The molecular identification, expression and cloning of membrane-bound organic cation transporters are being completed in isolated in vitro membranes. In vivo studies, where cation specificity overlaps, need to complement this work.
METHOD: Cross-inhibition of [3H]choline and [3H]thiamine brain uptake by in situ rat brain perfusion.
RESULTS: [3H]Choline brain uptake was not inhibited by thiamine at physiologic concentrations (100 nM). However, choline ranging from 100 nM to 250 microM inhibited [3H]thiamine brain uptake, though not below levels observed at thiamine concentrations of 100 nM.
CONCLUSION: (1) The molecular family of the blood-brain barrier (BBB) choline transporter may be elucidated in vitro by its interaction with physiologic thiamine levels, and (2) two cationic transporters at the BBB may be responsible for thiamine brain uptake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15672546     DOI: 10.1007/s11064-004-7032-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier.

Authors:  Y S Kang; T Terasaki; T Ohnishi; A Tsuji
Journal:  J Pharmacobiodyn       Date:  1990-06

2.  Molecular cloning of a human, hemicholinium-3-sensitive choline transporter.

Authors:  S Apparsundaram; S M Ferguson; A L George; R D Blakely
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

Review 3.  Organic cation transporters.

Authors:  H Koepsell; B M Schmitt; V Gorboulev
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-06-25       Impact factor: 5.545

Review 4.  Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system.

Authors:  Q R Smith
Journal:  Pharm Biotechnol       Date:  1996

Review 5.  Determination of thiamin and its phosphate esters in human blood, plasma, and urine.

Authors:  C M Tallaksen; T Bøhmer; J Karlsen; H Bell
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

6.  Small rises in plasma choline reverse the negative arteriovenous difference of brain choline.

Authors:  J Klein; A Köppen; K Löffelholz
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

7.  Carrier mediated blood-brain barrier transport of choline and certain choline analogs.

Authors:  E M Cornford; L D Braun; W H Oldendorf
Journal:  J Neurochem       Date:  1978-02       Impact factor: 5.372

8.  Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique.

Authors:  D D Allen; Q R Smith
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

9.  Evaluation of blood-brain barrier thiamine efflux using the in situ rat brain perfusion method.

Authors:  P R Lockman; R J Mumper; D D Allen
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

10.  Determination of thiamine in human plasma and its pharmacokinetics.

Authors:  W Weber; H Kewitz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  5 in total

1.  Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).

Authors:  Linda P Dwoskin; B Matthew Joyce; Guangrong Zheng; Nichole M Neugebauer; Vamshi K Manda; Paul Lockman; Roger L Papke; Michael T Bardo; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2007-07-21       Impact factor: 5.858

2.  Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter.

Authors:  Guangrong Zheng; Zhenfa Zhang; Paul R Lockman; Werner J Geldenhuys; David D Allen; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-04-24       Impact factor: 2.823

3.  Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Authors:  Werner J Geldenhuys; Vamshi K Manda; Rajendar K Mittapalli; Cornelis J Van der Schyf; Peter A Crooks; Linda P Dwoskin; David D Allen; Paul R Lockman
Journal:  Bioorg Med Chem Lett       Date:  2009-12-28       Impact factor: 2.823

4.  N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.

Authors:  Linda P Dwoskin; Thomas E Wooters; Sangeetha P Sumithran; Kiran B Siripurapu; B Matthew Joyce; Paul R Lockman; Vamshi K Manda; Joshua T Ayers; Zhenfa Zhang; Agripina G Deaciuc; J Michael McIntosh; Peter A Crooks; Michael T Bardo
Journal:  J Pharmacol Exp Ther       Date:  2008-05-06       Impact factor: 4.030

5.  A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives.

Authors:  Derrick Lonsdale
Journal:  Evid Based Complement Alternat Med       Date:  2006-03       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.